This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Decipher Genomic Classifier
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
WCET 2024
SUPS 2024
BCAN TT 2024
SNMMI 2024
ASCO 2024
AUA 2024
All Conferences
View All
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: Rationale and design - Abstract
May 22, 2012
Radiation-based approaches for therapy and palliation of advanced prostate cancer - Abstract
May 21, 2012
The Prostate cancer Research International - Abstract
May 21, 2012
Androgen action and metabolism in prostate cancer - Abstract
May 21, 2012
Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: First results from the STAMPEDE multiarm, multistage, randomised controlled trial - Abstract
May 21, 2012
Abiraterone in prostate cancer: A new angle to an old problem - Abstract
May 21, 2012
Management of synchronous rectal and prostate cancer - Abstract
May 21, 2012
Can choline PET tackle the challenge of imaging prostate cancer? - Abstract
May 21, 2012
Primary hormonal treatment in localized and locally advanced prostate cancer: Effectiveness and survival predictive factors - Abstract
May 21, 2012
AUA 2012 - Denosumab delays development of multiple bone metastases in men with castrate-resistant prostate cancer - Session Highlights
May 21, 2012
AUA 2012 - The absence of goal setting in the dialogue between metastatic prostate cancer (mCRPC) patients and their physicians: An opportunity for shared decision making? - Session Highlights
May 21, 2012
Combination therapy of antiandrogen and XIAP inhibitor for treating advanced prostate cancer - Abstract
May 21, 2012
Does salvage radiation therapy change the biology of recurrent prostate cancer based on PSA doubling times? Results from the SEARCH database - Abstract
May 21, 2012
AUA 2012 - Trends in the use of incontinence procedures after radical prostatectomy: A population-based analysis - Session Highlights
May 21, 2012
AUA 2012 - A comparison of biochemical recurrence rates of open and robotic prostatectomy at a large tertiary care center - Session Highlights
May 21, 2012
AUA 2012 - One year updated comparative cost analysis of open and robotic-assisted radical prostatectomy - Session Highlights
May 20, 2012
AUA 2012 - Urinary continence (UC) and sexual function (SF) among men with localized prostate cancer treated with active surveillance (AS), radical prostatectomy (RP), and brachytherapy (PI) - Session Highlights
May 20, 2012
Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance - Abstract
May 18, 2012
Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro - Abstract
May 18, 2012
Diffusion-weighted imaging with relative signal intensity statistical thresholding for delineating prostate cancer tumors - Abstract
May 18, 2012
Page 1274 of 1417
Start
Prev
1269
1270
1271
1272
1273
1274
1275
1276
1277
1278
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free